Effect of Virtual Reality on Pain and Anxiety in Women With Dysmenorrhea: A Randomized Controlled Trial
VR
1 other identifier
interventional
68
1 country
2
Brief Summary
Dysmenorrhea, or painful menstrual periods, is a common condition that can affect daily activities and quality of life. This study aims to evaluate whether using virtual reality (VR) can reduce pain and anxiety in women with primary dysmenorrhea. Participants will be randomly assigned to either a VR group or a 2D video group. Participants in the VR group will watch a relaxing virtual environment using a VR headset for 20 minutes once a day for three consecutive days. Participants in the 2D video group will watch the same content for the same duration and frequency using a 2D screen, such as a phone, tablet, or computer. Pain intensity and anxiety levels will be assessed before and after each session during the three-day intervention. The study will compare changes in pain and anxiety between the two groups to evaluate the effect of VR in women with primary dysmenorrhea.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Sep 2026
Shorter than P25 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 26, 2026
CompletedStudy Start
First participant enrolled
September 30, 2026
CompletedFirst Posted
Study publicly available on registry
October 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 30, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
November 30, 2026
October 1, 2026
September 1, 2026
1 month
September 26, 2026
September 26, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Visual Analog Scale (VAS)
This is used to quantify certain values that cannot be measured numerically. The two extremes of the parameter being evaluated are marked at either end of a 100 mm line, and the patient is asked to indicate their current status on this line by drawing a mark, placing a dot, or pointing. For pain assessment, "no pain" is written at one end and "severe pain" at the other; the patient then marks their current pain level on the line. The distance from the "no pain" end to the patient's mark represents the level of pain. Evaluation is performed by calculating the mean of the values obtained from the patients.
1-3. days
Secondary Outcomes (1)
State Anxiety Inventory (STAI-X)
1-3. days
Study Arms (2)
2D Video Group
ACTIVE COMPARATORParticipants will watch the same 20-minute relaxation video on a conventional 2D screen (e.g., tablet, smartphone, or computer) once daily for three consecutive days during the first three days of menstruation. Pain intensity and state anxiety will be assessed immediately before and after each session.
Virtual Reality Group
EXPERIMENTALParticipants will receive a 20-minute relaxation video through a virtual reality (VR) headset once daily for three consecutive days during the first three days of menstruation. Pain intensity and state anxiety will be assessed immediately before and after each session.
Interventions
A 20-minute relaxation video will be presented using a virtual reality (VR) headset. Participants will receive the intervention once daily for three consecutive days during the first three days of menstruation. The VR environment is designed to provide an immersive visual and auditory experience and to direct participants' attention away from menstrual pain.
Eligibility Criteria
You may qualify if:
- University students,
- Diagnosed with primary dysmenorrhea,
- Having a regular menstrual cycle,
- Willing to participate in the study,
- Having no vision or hearing problems.
You may not qualify if:
- Individuals diagnosed with secondary dysmenorrhea,
- Individuals experiencing chronic pelvic pain,
- Individuals with a psychiatric disorder,
- Individuals using hormonal therapy,
- Individuals using analgesics during menstruation,
- Individuals with visual or hearing impairments,
- Individuals wishing to withdraw at any stage of the study,
- Individuals who fill out the forms incompletely or fail to fill them out.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Tokat Gaziosmanpasa University
Erbaa, Tokat Province, 60500, Turkey (Türkiye)
Tokat Gaziosmanpasa University
Erbaa, Tokat Province, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- The study is open-label for participants, care providers, and investigators. The statistician/data analyst will be blinded to group allocation during the statistical analysis. Group assignments will be coded without identifying the intervention groups until the primary analyses have been completed.
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Lecturer
Study Record Dates
First Submitted
September 26, 2026
First Posted
October 1, 2026
Study Start
September 30, 2026
Primary Completion (Estimated)
October 30, 2026
Study Completion (Estimated)
November 30, 2026
Last Updated
October 1, 2026
Record last verified: 2026-09
Data Sharing
- IPD Sharing
- Will not share
Individual participant data will not be shared with other researchers. De-identified aggregate data will be reported in publications resulting from this study.